Record NNP B-NP O
date NN I-NP O
: : O O
2096-06-11 CD O B-DATE
Internal NNP B-NP O
Medicine NNP I-NP O
LANCASTER NNP B-NP B-HOSPITAL
MEMORIAL NNP I-NP I-HOSPITAL
HOSPITAL NNP I-NP I-HOSPITAL
Personal NNP B-NP O
data NNS I-NP O
and CC O O
overall JJ B-NP O
health NN I-NP O
Mr. NNP I-NP O
Jacobs NNP I-NP B-PATIENT
is VBZ B-VP O
a DT B-NP O
73 CD I-NP B-AGE
yoM NN I-NP O
with IN B-PP O
a DT B-NP O
history NN I-NP O
of IN B-PP O
NIDDM NNP B-NP O
, , O O
CAD NNP B-NP O
s/p VBD B-VP O
anteroseptal JJ B-NP O
MI NNP I-NP O
( -LRB- I-NP O
2092 CD I-NP B-DATE
) -RRB- I-NP O
w/ JJ I-NP O
stent JJ I-NP O
placement NN I-NP O
, , O O
AIHA NNP B-NP O
, , O O
BPPV. . O O
Reason NN B-NP O
for IN B-PP O
visit NN B-NP O
Follow-up NNP I-NP O
Visit NNP I-NP O
Problem NN B-NP O
List NN I-NP O
( -LRB- B-VP O
reviewed VBN I-VP O
) -RRB- O O
Diabetes NNP B-NP O
mellitus NN I-NP O
(adult NN I-NP O
onset NN I-NP O
) -RRB- B-NP O
MAJOR NN I-NP O
Atherosclerotic JJ B-NP O
coronary JJ I-NP O
vascular JJ I-NP O
disease NN I-NP O
MAJOR NN I-NP O
Health NNP B-NP O
maintenance NN I-NP O
MAJOR NN I-NP O
Anemia NNP B-NP O
MAJOR NN I-NP O
Smoking VBG B-NP O
status NN I-NP O
: : O O
former JJ B-NP O
smoker NN I-NP O
Major NNP B-NP O
Problems NNS I-NP O
Diabetes NNP B-NP O
mellitus NN I-NP O
(adult NN I-NP O
onset NN I-NP O
) -RRB- O O
Aug NNP B-NP B-DATE
13 CD I-NP I-DATE
S NNP B-NP O
: : O O
Has VBZ B-VP O
history NN B-NP O
of IN B-PP O
DM2 NNP B-NP O
for IN B-PP O
20( CD B-NP O
+)years NNS I-NP O
c/b IN B-PP O
peripheral JJ B-NP O
neuropathy NN I-NP O
for IN B-PP O
which WDT B-NP O
Mr. NNP B-NP O
Jacobs NNP I-NP B-PATIENT
takes VBZ B-VP O
amytriptyline NN B-NP O
with IN B-PP O
good JJ B-NP O
effect NN I-NP O
. . O O
He PRP B-NP O
has VBZ B-VP O
a DT B-NP O
hx NN I-NP O
of IN B-PP O
iritis NN B-NP O
and CC I-NP O
retinitis NN I-NP O
recently RB B-ADVP O
treated VBN B-VP O
with IN B-PP O
steroids NNS B-NP O
. . O O
He PRP B-NP O
follows-up VBD B-VP O
with IN B-PP O
the DT B-NP O
Rusk NNP I-NP B-HOSPITAL
State NNP I-NP I-HOSPITAL
opthamologists NNS I-NP O
. . O O
For IN B-PP O
foot NN B-NP O
care NN I-NP O
he PRP B-NP O
sees VBZ B-VP O
a DT B-NP O
podiatrist NN I-NP O
at IN B-PP O
the DT B-NP O
RSH NNP I-NP B-HOSPITAL
as RB B-ADVP O
well RB I-ADVP O
. . O O
There EX B-NP O
is VBZ B-VP O
no DT B-NP O
history NN I-NP O
of IN B-PP O
diabetic JJ B-NP O
ulcer NN I-NP O
or CC I-NP O
cellulitis NN I-NP O
. . O O
He PRP B-NP O
is VBZ B-VP O
maintained VBN I-VP O
on IN B-PP O
glyburide NN B-NP O
2.5mg CD I-NP O
for IN B-PP O
several JJ B-NP O
years NNS I-NP O
and CC O O
he PRP B-NP O
checks VBZ B-VP O
his PRP$ B-NP O
BS NNP I-NP O
qd NN I-NP O
with IN B-PP O
range NN B-NP O
of IN B-PP O
100-150 CD B-NP O
and CC O O
occasional JJ B-NP O
episodes NNS I-NP O
of IN B-PP O
hypoglycemia NN B-NP O
. . O O
His PRP$ B-NP O
last JJ I-NP O
AIC NN I-NP O
was VBD B-VP O
4.4 CD B-NP O
% NN I-NP O
in IN B-PP O
9/95 CD B-NP B-DATE
. . O O
At IN B-PP O
this DT B-NP O
time NN I-NP O
his PRP$ B-NP O
UA NNP I-NP O
showed VBD B-VP O
no DT B-NP O
proteinuria NN I-NP O
and CC O O
his PRP$ B-NP O
renal JJ I-NP O
function NN I-NP O
is VBZ B-VP O
within IN B-PP O
normal JJ B-NP O
limits NNS I-NP O
. . O O
He PRP B-NP O
is VBZ B-VP O
on IN B-PP O
an DT B-NP O
ACEi NNP I-NP O
. . O O
His PRP$ B-NP O
diabetic JJ I-NP O
care NN I-NP O
is VBZ B-VP O
well RB I-VP O
managed VBN I-VP O
at IN B-PP O
the DT B-NP O
Diabetic NNP I-NP O
clinic NN I-NP O
by IN B-PP O
Whitney NNP B-NP B-DOCTOR
Bullock NNP I-NP I-DOCTOR
. . O O
P NNP B-NP O
: : O O
c/w NN B-NP O
glyburide NN I-NP O
and CC O O
current JJ B-NP O
endocrine/optho/podiatry NN I-NP O
care NN I-NP O
. . O O
Atherosclerotic JJ B-NP O
coronary JJ I-NP O
vascular JJ I-NP O
disease NN I-NP O
S NNP B-NP O
: : O O
Mr. NNP B-NP O
Jacobs NNP I-NP B-PATIENT
has VBZ B-VP O
a DT B-NP O
hx NN I-NP O
of IN B-PP O
anteroseptal JJ B-NP O
MI NNP I-NP O
in IN B-PP O
2092 CD B-NP B-DATE
and CC O O
is VBZ B-VP O
s/p RB I-VP O
left VBN I-VP O
main JJ B-NP O
stent NN I-NP O
placement NN I-NP O
. . O O
In IN B-PP O
July NNP B-NP B-DATE
of IN B-PP I-DATE
2095 CD B-NP I-DATE
, , O O
he PRP B-NP O
had VBD B-VP O
a DT B-NP O
TTE NN I-NP O
which WDT B-NP O
was VBD B-VP O
remarkable JJ B-ADJP O
for IN B-PP O
an DT B-NP O
EF NN I-NP O
of IN B-PP O
23 CD B-NP O
% NN I-NP O
, , O O
reduced VBN B-VP O
from IN B-PP O
31 CD B-NP O
% NN I-NP O
in IN B-PP O
2092 CD B-NP B-DATE
. . O O
Also RB B-ADJP O
notable JJ I-ADJP O
for IN B-PP O
anteroseptal JJ B-NP O
AK NNP I-NP O
and CC I-NP O
infero-posterior JJ I-NP O
HK. NNP I-NP O
AD-MIB NNP I-NP O
I PRP B-NP O
in IN B-PP O
9/95 CD B-NP B-DATE
with IN B-PP O
anteroseptal JJ B-NP O
scar NN I-NP O
, , O O
but CC O O
no DT B-NP O
ischemia NN I-NP O
. . O O
Does VBZ B-VP O
about IN B-NP O
30 CD I-NP O
minutes NNS I-NP O
of IN B-PP O
aerobic JJ B-NP O
physical JJ I-NP O
activity NN I-NP O
each DT B-NP O
morning NN I-NP O
without IN B-PP O
issue NN B-NP O
. . B-PP O
No DT B-NP O
CP NNPS I-NP O
or CC I-NP O
SOB. NNP I-NP O
Denies NNS I-NP O
orthopnea NN I-NP O
, , O O
PND NNP B-NP O
, , O O
LE JJ B-NP O
edema NN I-NP O
. . O O
P NNP B-NP O
: : O O
DM NNP B-VP O
( -LRB- B-NP O
AIC NN I-NP O
4.4 CD I-NP O
) -RRB- I-NP O
and CC I-NP O
lipid JJ I-NP O
control NN I-NP O
( -LRB- B-PP O
LDL JJ B-NP O
59 CD I-NP O
) -RRB- I-NP O
is VBZ B-VP O
optimal JJ B-ADJP O
. . O O
Medical NNP B-NP O
Regimen NNP I-NP O
consists VBZ B-VP O
of IN B-PP O
ASA NNP B-NP O
, , O O
BB NNP B-NP O
, , O O
ACEi NNP B-NP O
, , O O
Statin NNP B-NP O
. . O O
Is VBZ O O
a DT B-NP O
patient NN I-NP O
of IN B-PP O
Dr. NNP B-NP O
Dunham NNP I-NP B-DOCTOR
and CC I-NP O
plan NN I-NP O
to TO B-VP O
see VB I-VP O
him PRP B-NP O
annually RB B-ADVP O
. . O O
I PRP B-NP O
wonder VBP B-VP O
if IN B-SBAR O
he PRP B-NP O
should MD B-VP O
be VB I-VP O
anticoagulated VBN I-VP O
given VBN I-VP O
his PRP$ B-NP O
diffuse JJ I-NP O
HK NN I-NP O
and CC O O
whether IN B-SBAR O
he PRP B-NP O
should MD B-VP O
be VB I-VP O
considered VBN I-VP O
for IN B-PP O
BiV NNP B-NP O
pacing NN I-NP O
. . O O
Health NNP B-NP O
maintenance NN I-NP O
CAD NN B-NP O
: : O O
please VB B-VP O
see VB I-VP O
problem NN B-NP O
list NN I-NP O
Tob NNP B-NP O
: : O O
quit VB B-VP O
25 CD B-NP O
years NNS I-NP O
ago RB B-SBAR O
EtOH NNP B-NP O
: : O O
neg NN B-NP O
Exercise NN B-NP O
: : O O
intensive JJ B-NP O
exercise NN I-NP O
regimen NN I-NP O
, , O O
but CC O O
limited JJ B-ADVP O
as IN B-PP O
of IN B-PP O
late JJ B-NP O
by IN B-PP O
neuropathy NN B-NP O
Diet NNP B-NP O
: : O O
eats VBZ B-VP O
fruits/vegetables NNS B-NP O
; : O O
minimal JJ B-NP O
salt NN I-NP O
, , O O
fatty JJ B-NP O
foods NNS I-NP O
Colon NNP B-NP O
CA NNP I-NP O
: : O O
Spring NNP B-NP B-DATE
2095 CD I-NP I-DATE
with IN B-PP O
normal JJ B-NP O
colonoscopy NN I-NP O
Prostate NNP B-NP O
CA NNP I-NP O
: : O O
next JJ B-NP O
due JJ I-NP O
for IN B-PP O
prostate NN B-NP O
exam NN I-NP O
in IN B-PP O
7/96 CD B-NP B-DATE
. . O O
Documented VBD B-VP O
more RBR B-ADVP O
than IN I-ADVP O
once RB I-ADVP O
in IN B-PP O
recent JJ B-NP O
inpatient JJ I-NP O
stay NN I-NP O
as IN B-PP O
non-enlarged JJ B-NP O
, , O O
no DT B-NP O
nodules NNS I-NP O
. . O O
PSA NNP B-NP O
checked VBD B-VP O
at IN B-PP O
RSH NNP B-NP B-HOSPITAL
and CC O O
is VBZ B-VP O
nl JJ B-ADJP O
per IN B-PP O
patient NN B-NP O
. . O O
Will MD B-VP O
request VB I-VP O
RSH NNP B-NP B-HOSPITAL
records NNS I-NP O
. . O O
Seatbelts NNS B-NP O
: : O O
y NN B-NP O
Sunscreen NNP B-NP O
: : O O
y NN B-NP O
Vaccines NNPS O O
: : O O
gets VBZ B-VP O
tetanus/pneumo NN B-NP O
at IN B-PP O
RSH NNP B-NP B-HOSPITAL
( -LRB- I-NP O
2095 CD I-NP B-DATE
) -RRB- I-NP O
and CC I-NP O
flu NN I-NP O
shot NN I-NP O
in IN B-PP O
the DT B-NP O
fall NN I-NP O
. . O O
Anemia NN B-NP O
History NN B-NP O
of IN B-PP O
Warm NNP B-NP O
Autoimmune NNP I-NP O
Hemolytic NNP I-NP O
Anemia NNP I-NP O
. . O O
Had VBD B-VP O
Hct NNP B-NP O
checked VBN B-VP O
in IN B-PP O
April NNP B-NP B-DATE
and CC O O
it PRP B-NP O
was VBD B-VP O
37 CD B-NP O
. . O O
Is VBZ B-VP O
not RB O O
light-headed JJ B-ADJP O
, , O O
short JJ B-ADJP O
of IN B-PP O
breathe VB B-NP O
, , O O
and CC O O
denies VBZ B-VP O
any DT B-NP O
chest NN I-NP O
pain NN I-NP O
. . O O
Allergies . O O
Allergy NNP B-NP O
Gets NNP I-NP O
rash NN I-NP O
with IN B-PP O
acetaminophen NNS B-NP O
Active NNP B-NP O
Medications NNPS I-NP O
glipizide NN B-NP O
2.5mg CD I-NP O
po NN I-NP O
qd NN I-NP O
QTY NNP B-NP O
:90 CD I-NP O
Refills NNS I-NP O
:4 . O O
lisinopril NN B-NP O
5 CD I-NP O
mg NN I-NP O
po NN I-NP O
qd VBD B-VP O
QTY NNP B-NP O
:90 CD I-NP O
Refills NNS I-NP O
:4 . O O
nitroglycerin IN B-PP O
0.4 CD B-NP O
mg NN I-NP O
SL NNP I-NP O
Q NNP I-NP O
5 CD I-NP O
minutes NNS I-NP O
, , O O
x NN B-NP O
3 CD I-NP O
prn NN I-NP O
chect NN I-NP O
pain NN I-NP O
QTY NNP B-NP O
:100 CD I-NP O
Refills NNP I-NP O
:12 CD I-NP O
metoprolol NN B-NP O
50mg JJ I-NP O
po NN I-NP O
bid NN I-NP O
QTY NNP B-NP O
:180 CD I-NP O
Refills NNS I-NP O
:4 . O O
atorvastatin IN B-PP O
10 CD B-NP O
mg JJ I-NP O
po NN I-NP O
qd NN I-NP O
QTY NNP B-NP O
:90 CD I-NP O
Refills NNP I-NP O
:4 CD I-NP O
psyllium NN B-NP O
powder NN I-NP O
1 CD I-NP O
tsp NN I-NP O
po NN I-NP O
bid NN I-NP O
please VBP B-VP O
give VB I-VP O
sugar NN B-NP O
free JJ I-NP O
psyllium NN I-NP O
QTY NN I-NP O
:x15ounces VBZ B-VP O
Refills NNP B-NP O
:12 CD I-NP O
aspirin NN B-NP O
81 CD I-NP O
mg NN I-NP O
po NN I-NP O
qd VBD B-VP O
QTY:30 CD B-NP O
Refills NNS I-NP O
:1 . O O
yr NN O O
Muro NNP B-NP O
128 CD I-NP O
1 CD I-NP O
drop NN I-NP O
each DT B-NP O
eye NN I-NP O
bedtime NN I-NP O
apply VBP B-VP O
to TO B-PP O
both DT B-NP O
eyes NNS I-NP O
at IN B-PP O
bedtime NN B-NP O
. . O O
QTY '' O O
:1 CD B-NP O
Refills NNPS I-NP O
:12 . O O
sodium NN B-NP O
chloride NN I-NP O
one CD B-NP O
drop NN I-NP O
each DT B-NP O
eye NN I-NP O
qid VBD B-VP O
apply VB I-VP O
one CD B-NP O
drop NN I-NP O
to TO B-PP O
each DT B-NP O
eye NN I-NP O
four CD B-NP O
times NNS I-NP O
a DT B-NP O
day NN I-NP O
. . O O
QTY NN O O
:1 VBD B-VP O
Refills NNP B-NP O
:12 CD I-NP O
amitriptyline IN B-PP O
25 CD B-NP O
mg NN I-NP O
po NN I-NP O
qhs NNS I-NP O
QTY JJ B-VP O
:90 CD B-NP O
Refills NNS I-NP O
:4 . O O
Change NNP B-NP O
in IN B-PP O
therapies NNS B-NP O
and CC I-NP O
Renewals NNS I-NP O
glipizide NN B-NP O
2.5mg CD I-NP O
po NN I-NP O
qd NN I-NP O
QTY NNP B-NP O
:90 CD I-NP O
Refills NNP I-NP O
:4 CD I-NP O
Start NNP I-NP O
: : O O
11/03/2092 CD O B-DATE
lisinopril NN B-NP O
5 CD I-NP O
mg NN I-NP O
po NN I-NP O
qd VBD B-VP O
QTY NNP B-NP O
:90 CD I-NP O
Refills NNP I-NP O
:4 CD I-NP O
Start NNP I-NP O
: : O O
11/03/2092 CD O B-DATE
nitroglycerin IN B-PP O
0.4 CD B-NP O
mg NN I-NP O
SL NNP I-NP O
Q NNP I-NP O
5 CD I-NP O
minutes NNS I-NP O
, , O O
x NN B-NP O
3 CD I-NP O
QTY NN I-NP O
:100 CD I-NP O
Refills NNP I-NP O
:12 CD I-NP O
Start NNP I-NP O
: : O O
11/03/2092 CD B-NP B-DATE
prn NN I-NP O
chect NN I-NP O
pain NN I-NP O
metoprolol NN B-NP O
50mg JJ I-NP O
po NN I-NP O
bid NN I-NP O
QTY NNP B-NP O
:180 CD I-NP O
Refills NNP I-NP O
:4 CD I-NP O
Start NNP I-NP O
: : O O
11/03/2092 CD O B-DATE
atorvastatin IN B-PP O
10 CD B-NP O
mg JJ I-NP O
po NN I-NP O
qd NN I-NP O
QTY NNP B-NP O
:90 CD I-NP O
Refills NNP I-NP O
:4 CD I-NP O
Start NNP I-NP O
: : O O
11/03/2092 CD O B-DATE
psyllium NN B-NP O
powder NN I-NP O
1 CD I-NP O
tsp NN I-NP O
po NN I-NP O
bid NN I-NP O
QTY NNP I-NP O
:x15ounces VBZ B-VP O
Refills NNP B-NP O
:12 CD I-NP O
Start NNP I-NP O
: : O O
11/03/2092 CD B-NP B-DATE
please VBP B-VP O
give VB I-VP O
sugar NN B-NP O
free JJ B-NP O
psyllium NN I-NP O
aspirin NN B-NP O
81 CD I-NP O
mg NN I-NP O
po NN I-NP O
qd VBD B-VP O
QTY:30 CD B-NP O
Refills NNS I-NP O
:1 IN B-PP O
yr JJ B-NP O
Start NNP I-NP O
: : O O
11/03/2092 CD O B-DATE
Muro NNP B-NP O
128 CD I-NP O
1 CD I-NP O
drop NN I-NP O
each DT B-NP O
eye NN I-NP O
bedtime NN I-NP O
QTY NNP B-NP O
:1 CD I-NP O
Refills NNP I-NP O
:12 CD I-NP O
Start NNP I-NP O
: : O O
5/05/2093 CD B-NP B-DATE
apply VBP B-VP O
to TO B-PP O
both DT B-NP O
eyes NNS I-NP O
at IN B-PP O
bedtime NN B-NP O
. . O O
sodium NN B-NP O
chloride NN I-NP O
one CD B-NP O
drop NN I-NP O
each DT B-NP O
eye NN I-NP O
qid VBD B-VP O
QTY NNP B-NP O
:1 CD I-NP O
Refills NNP I-NP O
:12 CD I-NP O
Start NNP I-NP O
: : O O
5/05/2093 CD B-NP B-DATE
apply VBP B-VP O
one CD B-NP O
drop NN I-NP O
to TO B-PP O
each DT B-NP O
eye NN I-NP O
four CD B-NP O
times NNS I-NP O
a DT B-NP O
day NN I-NP O
. . O O
amitriptyline IN B-PP O
25 CD B-NP O
mg NN I-NP O
po NN I-NP O
qhs NNS I-NP O
QTY JJ B-VP O
:90 CD B-NP O
Refills NNS I-NP O
:4 IN B-PP O
Start NNP B-NP O
: : O O
10/12/2094 CD O B-DATE
Iron NNP B-NP O
sulfate NN I-NP O
325mg JJ B-NP O
PO NNP I-NP O
QD NNP I-NP O
QTY:30 CD I-NP O
Refills NNP I-NP O
:3 CD I-NP O
Start NNP I-NP O
: : O O
1/11/2096 CD B-NP B-DATE
End NN I-NP O
: : O O
6/11/2096 CD B-NP B-DATE
take NN I-NP O
with IN B-PP O
food NN B-NP O
once RB B-ADVP O
daily RB B-ADVP O
. . O O
- : O O
Inactivated CC O O
Colace NNP B-NP O
100 CD I-NP O
mg JJ I-NP O
po NN I-NP O
bid NN I-NP O
QTY NNP B-NP O
:180 CD I-NP O
Refills NNP I-NP O
:3 CD I-NP O
Start NNP I-NP O
: : O O
1/11/2096 CD B-NP B-DATE
End NN I-NP O
: : O O
6/11/2096 CD B-NP B-DATE
- : O O
Inactivated CC O O
Past JJ B-NP O
medical JJ I-NP O
history NN I-NP O
DM IN B-PP O
x NN B-NP O
20 CD I-NP O
years NNS I-NP O
, , O O
peripheral JJ B-NP O
neuropathy NN I-NP O
HTN . O O
CAD NN B-NP O
Anteroseptal NNP B-NP O
MI NNP I-NP O
in IN B-PP O
03/09 CD B-NP B-DATE
, , O O
PTCA NNP B-NP O
and CC O O
stent NN B-NP O
EF NNP B-NP O
23 CD I-NP O
% NN I-NP O
( -LRB- I-NP O
last JJ B-NP O
echo NN I-NP O
2095 . O B-DATE
) -RRB- O O
S/P NNP B-NP O
Hemorrhoidectomy NNP I-NP O
2096 CD O B-DATE
Iritis NNP B-NP O
, , O O
corneal NN B-NP O
dystrophy NN I-NP O
Osteoporosis NN B-NP O
Rheumatoid VB B-NP O
arthritis NN I-NP O
- : O O
affecting VBG B-VP O
small JJ B-NP O
joints NNS I-NP O
of IN B-PP O
hands NNS B-NP O
and CC O O
back RB B-ADVP O
. . O O
Had VBD B-VP O
iritis NN I-VP O
as RB B-ADVP O
well RB I-ADVP O
and CC O O
told VBD B-VP O
the DT B-NP O
two CD I-NP O
were VBD B-VP O
linked VBN I-VP O
. . O O
Has VBZ B-VP O
not RB I-VP O
been VBN I-VP O
told VBN I-VP O
has VBZ B-PP O
ank NN B-NP O
. . B-NP O
spond NN I-NP O
. . O O
or CC O O
psoriatic JJ B-ADJP O
. . O O
Not RB B-ADJP O
active JJ I-ADJP O
at IN B-PP O
present JJ B-ADJP O
. . O O
Basal NNP B-NP O
Cell NNP I-NP O
CA NNP I-NP O
: : O O
removed VBN B-VP O
in IN B-PP O
2094 CD B-NP B-DATE
Warm NNP B-NP O
autoimmune NN I-NP O
hemolytic NN I-NP O
anemia NN I-NP O
Family NN B-NP O
history NN I-NP O
NC NNP I-NP O
Social JJ B-NP O
history NN I-NP O
Divorced VBD B-VP O
. . B-NP O
7 CD I-NP O
children NNS I-NP O
, , O O
15 CD B-NP O
grandchildren NNS I-NP O
. . O O
Worked NNP O O
as IN B-PP O
a DT B-NP O
biological JJ I-NP B-PROFESSION
technologist NN I-NP I-PROFESSION
. . O O
Ex NNP B-NP O
smoker NN I-NP O
, , O O
quit VBD B-VP O
25 CD B-NP O
years NNS I-NP O
ago RB B-ADVP O
; : O O
(-) DT B-NP O
EtOH NNP I-NP O
since IN B-PP O
2078 CD B-NP B-DATE
but CC O O
previously RB B-NP O
heavy JJ I-NP O
drinking NN I-NP O
hx NN I-NP O
; : O O
minimal JJ B-NP O
C2H5 NNP I-NP O
. . O O
Lives NNS B-NP O
in IN B-PP O
Dushanbe DT B-NP B-CITY
apartment NN I-NP O
community NN I-NP O
. . O O
Review NNP B-NP O
of IN B-PP O
systems NNS B-NP O
All DT B-NP O
other JJ I-NP O
systems NNS I-NP O
negative JJ B-ADJP O
in IN B-PP O
detail NN B-NP O
. . O O
Physical JJ B-NP O
examination NN I-NP O
Blood NN B-NP O
pressure NN I-NP O
100/60 CD B-NP O
R=L NNS I-NP O
Pulse NNP B-NP O
60 CD I-NP O
on IN B-PP O
BB NNP B-NP O
Weight NNP B-NP O
194 CD I-NP O
Height NN B-NP O
194 CD I-NP O
General NNP B-NP O
appearance NN I-NP O
Well RB B-VP O
developed VBN I-VP O
, , O O
well RB B-VP O
nourished VBN I-VP O
, , O O
no DT B-NP O
acute JJ I-NP O
distress NN I-NP O
. . O O
Heent NNP B-NP O
NC/AT NNP I-NP O
, , O O
PERRL NNP B-NP O
, , O O
EOMI NNP B-NP O
, , O O
O/P RB B-ADVP O
clear JJ B-ADJP O
without IN B-PP O
erythema NN B-NP O
or CC I-NP O
exudates NNS I-NP O
. . O O
Neck NNP B-NP O
JVP NNP I-NP O
flat JJ I-NP O
; : O O
carotids NNS B-NP O
brisk JJ B-NP O
, , I-NP O
2+ JJ I-NP O
bilaterally RB B-ADVP O
without IN B-PP O
bruits NNS B-NP O
, , O O
no DT B-NP O
goiter NN I-NP O
. . O O
Chest NNP B-NP O
Clear NNP I-NP O
to TO B-PP O
auscultation NN B-NP O
bilaterally RB B-ADVP O
. . O O
Cor NNP B-NP O
PMI NNP I-NP O
at IN B-PP O
5th JJ B-NP O
ICS NNP I-NP O
, , O O
MCL. NNP B-NP O
RRR NNP I-NP O
nl NN I-NP O
s1 VBD B-VP O
, , O O
s2 VBD B-VP O
without IN B-PP O
m/r/g NN B-NP O
. . O O
Abdomen NNP B-NP O
NT/ND NNP I-NP O
, , O O
no DT B-NP O
HSM. NNP I-NP O
Normal NNP I-NP O
active JJ I-NP O
bowel NN I-NP O
sounds NNS I-NP O
. . O O
Extrem NNP B-NP O
All DT I-NP O
pulses NNS I-NP O
palpable JJ B-ADJP O
, , O O
no DT B-NP O
loss NN I-NP O
of IN B-PP O
hair NN B-NP O
, , O O
cap NN B-NP O
refill NN I-NP O
excellent JJ I-NP O
. . O O
Feet NNP B-NP O
are VBP B-VP O
warm JJ B-ADJP O
, , O O
no DT B-NP O
trauma NN I-NP O
or CC I-NP O
infection NN I-NP O
Musc NNP B-NP O
skel NN I-NP O
No DT B-NP O
bony JJ I-NP O
deformities NNS I-NP O
. . O O
Assessment NNP B-NP O
and CC I-NP O
plan NN I-NP O
Recheck VBP B-VP O
HCT NNP B-NP O
today NN B-NP O
. . O O
Follow-up NN B-NP O
with IN B-PP O
Dr. NNP B-NP O
Duarte NNP I-NP B-DOCTOR
re VBD B-VP O
issue NN B-NP O
of IN B-PP O
anticoagulation NN B-NP O
and CC O O
BiV JJ B-NP O
pacing NN I-NP O
. . O O
RTC NNP O O
in IN B-PP O
3-4 CD B-NP O
months NNS I-NP O
for IN B-PP O
annual JJ B-NP O
physical JJ I-NP O
exam NN I-NP O
. . O O
Disposition NN B-NP O
Signed VBN B-VP O
electronically RB B-ADVP O
by IN B-PP O
Fagan NNP B-NP I-DOCTOR
, , O I-DOCTOR
Kory NNP B-NP I-DOCTOR
on IN B-PP O
Jun NNP B-NP B-DATE
11 CD I-NP I-DATE
, , I-NP I-DATE
2096 CD O I-DATE
